FDA Approval Activities for this Drug…

AVODART (dutasteride) soft-gelatin capsules, GlaxoSmithKline NDA 21-319/S-001 Duagen (Dutasteride) Soft gel Capsules, 0.5 mg, GlaxoSmithKline NDA 21-319 11/20/01 1/14/02 Dutasteride Indications: for the signs and symptoms of benign prostatic hyperplasia. AVODART (dutasteride) soft-gelatin capsules, GlaxoSmithKline Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Labeling Revision Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Efficacy Supplement with Clinical Data to Support Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Efficacy Supplement with Clinical Data to Support Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Supplement

For the latest approval information, please locate this drug using this index.